Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.243
Delayed Data
As of Feb 27
 +0.01 / +4.29%
Today’s Change
0.21
Today|||52-Week Range
0.49
-2.80%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Hemispherx Biopharma Inc have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a +517.28% increase from the last price of 0.24.

Analyst Recommendations

There are no recommendations available.

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
--
Sales
-$32.8B
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
 
 
Growthannually -10.00%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually 279.26%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account